First Bank & Trust
- SEC CIK
- 0001692632
- Latest filing
- Jul 9, 2026
GSK holding history
GSK plc in every 13F filed by First Bank & Trust, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q2 2026 holdings
- Shares (Q2 2026)
- 41,519
- Value
- $2.18M
- % of portfolio
- 0.3%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 41,519 | $2.18M | 0.3% | −6,252−13.1% | Reduced | Holders |
| Q1 2026 | 47,771 | $2.64M | 0.4% | −8,562−15.2% | Reduced | Holders |
| Q4 2025 | 56,333 | $2.76M | 0.5% | +5,182+10.1% | Added | Holders |
| Q3 2025 | 51,151 | $2.21M | 0.4% | +19,484+61.5% | Added | Holders |
| Q2 2025 | 31,667 | $1.22M | 0.2% | +31,667 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −163−100.0% | Sold out | Holders |
| Q1 2022 | 163 | $7.00K | <0.1% | −372−69.5% | Reduced | Holders |
| Q4 2021 | 535 | $24.0K | <0.1% | −30−5.3% | Reduced | Holders |
| Q3 2021 | 565 | $22.0K | <0.1% | −135−19.3% | Reduced | Holders |
| Q2 2021 | 700 | $28.0K | <0.1% | −837−54.5% | Reduced | Holders |
| Q1 2021 | 1,537 | $55.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.